Russell Investments Group, Ltd. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$927,000
+30.6%
55,502
+12.5%
0.00%0.0%
Q1 2020$710,000
+16.0%
49,334
+92.6%
0.00%
+100.0%
Q4 2018$612,000
-11.3%
25,614
+1.4%
0.00%0.0%
Q3 2018$690,000
+34.5%
25,251
+32.6%
0.00%0.0%
Q2 2018$513,000
-15.2%
19,0360.0%0.00%0.0%
Q1 2018$605,000
-51.8%
19,036
-41.2%
0.00%
-50.0%
Q4 2017$1,255,000
-23.8%
32,377
-51.3%
0.00%
-33.3%
Q3 2017$1,648,000
+209.8%
66,454
+156.6%
0.00%
+200.0%
Q2 2017$532,000
-24.9%
25,897
-20.5%
0.00%0.0%
Q1 2017$708,000
-58.6%
32,579
-60.9%
0.00%
-66.7%
Q4 2016$1,711,00083,3360.00%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders